Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response

Clinical trial NCT07767110 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07767110
Sponsor: NanOlogy, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Midline Glioma (DMG)Diffuse Intrinsic Pontine Glioma (DIPG)Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma

Start date: 2026-12-01
Primary completion: 2029-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.